Literature DB >> 10877917

Glial cell line-derived neurotrophic factor stimulates the morphological differentiation of cultured ventral mesencephalic calbindin- and calretinin-expressing neurons.

H R Widmer1, B Schaller, M Meyer, R W Seiler.   

Abstract

Glial cell line-derived neurotrophic factor (GDNF) is a potent neurotrophic factor for mesencephalic dopaminergic neurons. Subpopulations of these neurons express the calcium-binding proteins calbindin (CB) and calretinin (CR). Understanding the specific effects of GDNF on these neurons is important for the development of an optimal cell replacement therapy for Parkinson's disease. To investigate the effects of GDNF on the morphological complexity of mesencephalic tyrosine hydroxylase (TH)-immunoreactive (-ir), CB-ir, and CR-ir neurons, dissociated cultures of embryonic (E14) rat ventral mesencephalon were prepared. Chronic administration of GDNF (10 ng/ml) for 7 days promoted the survival of TH-ir and CB-ir neurons but did not alter the density of CR-ir neurons. Total fiber length/neuron and number of branching points/neuron of CB-ir and CR-ir cells were significantly increased after GDNF treatment (2x for CB-ir cells and 1.4x and 1.7x, respectively, for CR-ir cells), which resulted in a significantly larger size of neurite field/neuron (2.9x and 1.5x for CB-ir and CR-ir neurons, respectively). The number of primary neurites/neuron of CB-ir neurons was found to be 1.5x larger, while no difference could be detected for CR-ir cells. Assessment of the effects of GDNF on TH-ir neurons unveiled a similar outcome with an increased total fiber length/neuron (1.5x), an increased number of primary neurites/neuron (1.6x), and a twofold larger size of neurite field/neuron. In conclusion, our findings recognize GDNF as a neurotrophic factor that stimulates the morphological differentiation of ventral mesencephalic CB-ir and CR-ir neurons. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10877917     DOI: 10.1006/exnr.2000.7418

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  13 in total

Review 1.  Roles for the TGFβ superfamily in the development and survival of midbrain dopaminergic neurons.

Authors:  Shane V Hegarty; Aideen M Sullivan; Gerard W O'Keeffe
Journal:  Mol Neurobiol       Date:  2014-02-07       Impact factor: 5.590

2.  Enhanced differentiation of human dopaminergic neuronal cell model for preclinical translational research in Parkinson's disease.

Authors:  Dilshan S Harischandra; Dharmin Rokad; Shivani Ghaisas; Saurabh Verma; Alan Robertson; Huajun Jin; Vellareddy Anantharam; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-08-20       Impact factor: 5.187

Review 3.  The role of growth/differentiation factor 5 (GDF5) in the induction and survival of midbrain dopaminergic neurones: relevance to Parkinson's disease treatment.

Authors:  Aideen M Sullivan; Gerard W O'Keeffe
Journal:  J Anat       Date:  2005-09       Impact factor: 2.610

4.  A synthetic five amino acid propeptide increases dopamine neuron differentiation and neurochemical function.

Authors:  O M Littrell; J L Fuqua; A D Richardson; J Turchan-Cholewo; E R Hascup; P Huettl; F Pomerleau; L H Bradley; D M Gash; G A Gerhardt
Journal:  Neuropeptides       Date:  2012-09-13       Impact factor: 3.286

5.  VGluT2 Expression in Dopamine Neurons Contributes to Postlesional Striatal Reinnervation.

Authors:  Willemieke M Kouwenhoven; Guillaume Fortin; Anna-Maija Penttinen; Clélia Florence; Benoît Delignat-Lavaud; Marie-Josée Bourque; Thorsten Trimbuch; Milagros Pereira Luppi; Alix Salvail-Lacoste; Pascale Legault; Jean-François Poulin; Christian Rosenmund; Raj Awatramani; Louis-Éric Trudeau
Journal:  J Neurosci       Date:  2020-09-14       Impact factor: 6.167

6.  Establishment of a survival and toxic cellular model for Parkinson's disease from chicken mesencephalon.

Authors:  Amparo Tolosa; Xiaolai Zhou; Björn Spittau; Kerstin Krieglstein
Journal:  Neurotox Res       Date:  2012-12-13       Impact factor: 3.911

7.  In vitro differentiation of neural stem cells into noradrenergic-like cells.

Authors:  Vahid Pirhajati Mahabadi; Mansoureh Movahedin; Saeed Semnanian; Javad Mirnajafi-Zadeh; Mehrdad Faizi
Journal:  Int J Mol Cell Med       Date:  2015

8.  A Combination of NT-4/5 and GDNF Is Favorable for Cultured Human Nigral Neural Progenitor Cells.

Authors:  Stefano Di Santo; Morten Meyer; Angélique D Ducray; Lukas Andereggen; Hans R Widmer
Journal:  Cell Transplant       Date:  2018-04-27       Impact factor: 4.064

9.  Regulated expression of lentivirus-mediated GDNF in human bone marrow-derived mesenchymal stem cells and its neuroprotection on dopaminergic cells in vitro.

Authors:  Wei-Hua Yang; Chun Yang; Yue-Qiang Xue; Tao Lu; Jakob Reiser; Li-Ru Zhao; Wei-Ming Duan
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

10.  Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells.

Authors:  Ana Sofia Correia; Sergey V Anisimov; Laurent Roybon; Jia-Yi Li; Patrik Brundin
Journal:  Front Neuroanat       Date:  2007-12-30       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.